Guest guest Posted July 7, 2011 Report Share Posted July 7, 2011 Pharmasset inks collaborative deal with J & J unit to develop hep C combo drug Proactive Investors USA & Canada " We are excited to be working with Tibotec to simplify and improve hepatitis treatment, " said Pharmasset's senior vice president, Bill Symonds. Earlier this year, Pharmasset announced its collaboration with Bristol-Myers Squibb (NYSE:BMY) to test that ... See all stories on this topic »Medco to Better Tackle Hepatitis C Zacks.com Medco Health Solutions (MHS - Analyst Report) is making attempts to curtail costs of treating patients suffering from hepatitis C (HCV). The company's specialty pharmacy segment, Accredo Health Group, considers patient adherence to the treatment most ... See all stories on this topic » Universal screening for hepatitis C supported by patients HemOncToday Patients with hepatitis C support universal screening for the disease, even if the testing is conducted without patient consent, according to researchers from the University of Washington in Seattle. In the United States, there are 2.9 million to 3.7 ... See all stories on this topic »Medivir: TMC435 has Received Fast Track Designation from the FDA and TMC435 ... MarketWatch (press release) Medivir today announced that its investigational protease inhibitor TMC435 has received " Fast Track " designation by the US Food and Drug Administration ( " FDA " ) for the treatment of chronic hepatitis C (CHC) genotype-1 infection. ... See all stories on this topic »Pharmasset to collaborate on a safer, simpler hepatitis C drug; CytRx touts ... FierceBiotech Item | Follow @CFierce > Pharmasset has forged a collaboration pact with Tibotec Pharmaceuticals, agreeing to evaluate the safety and efficacy of a combined product for hepatitis C in a mid-stage study. Pharmasset release > CytRx reports that its ... See all stories on this topic »Nishtar to treat free 70 hepatitis patients Pakistan Observer Multan—Social welfare committee of Nishtar hospital has approved need-based free treatment for 70 patients suffering hepatitis-C. A meeting was held under the chair of MS Dr Zafar Alwi on Wednesday while other members of committee, including AMS Dr ... See all stories on this topic »Accredo helps hepatitis C patients save up to $13K Drug Store News FRANKLIN LAKES, NJ — Pharmacy benefit manager Medco Health Solutions' specialty pharmacy division, Accredo Health Group, has managed to drive down costs for treating hepatitis C by an average of $13000 per patient, the company said Tuesday. ... See all stories on this topic »Woman with disease charged with assault phillyBurbs.com PERKASIE — Lin struggled with officers attempting to arrest her on a public drunkenness charge, spit repeatedly in one officer's face and laughed, " I have Hepatitis C, ha, ha, " according to court records. ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.